secwatch.observer — SEC 8-K summary
======================================

Issuer:     Onconetix, Inc. (ONCO)
CIK:        0001782107
Form:       8-K
Filed at:   2023-09-22T23:59:59+00:00
Accession:  0001213900-23-078811
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Blue Water Biotech (BWV) receives Nasdaq bid price deficiency notice
--------------------------------------------------------------------

- Notice from Nasdaq on Sept 18, 2023 for closing bid below $1.00 for 30 consecutive days.
- Company has 180 days, until March 16, 2024, to regain compliance by closing at $1.00+ for 10 days.
- May qualify for second 180-day compliance period; considering reverse stock split if needed.
- No immediate effect on listing; company monitoring options.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782107/000121390023078811/0001213900-23-078811-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782107/000121390023078811/ea185612-8k_bluewater.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-078811

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer